-
Article | 2020.10.02
PATENTS AND INVENTIONS
Nicolas Torno,Associate VP and Head of OfficeThe Patents and Inventions Office is tasked with protecting intellectual property rights at the Institut Pasteur, which holds a portfolio of approximately 2,150 patents and 211 patent families.The Patents and Inventions Office is not only responsible for going through all the legal steps in protection but also works closely with other offices and...
-
Article | 2020.10.02
DETECTION, FINANCING OF INNOVATION & ENTREPRENEURSHIP OFFICE
Detection, Financing Of Innovation & Entrepreneurship Office Dr. Daniel Larzul, Head of Office The Detection, Financing of Innovation & Entrepreneurship Office is involved in early identification of innovative research...
-
Article | 2020.10.05
INDUSTRIAL AGREEMENTS - POST CONTRACT & STRATEGIC ALLIANCE
Industrial Agreements OfficeCamille Tribout, Head of OfficeThe Industrial Agreements Office (SAI) is responsible for all aspects of post-contract management and is the point of contact once a contract has been signed. Alliance management is also in place with strategic partners. In addition, the Industrial Agreements Office is responsible for: financial flows resulting from technology...
-
Article | 2020.10.05
TECHNOLOGY TRANSFER
Technology Transfer And Business Development OfficeLinda Nait-Kaoudjt, Head of OfficeThe aim of the Technology Transfer Office is to develop partnerships with industrial partners and to increase contract volumes. In order to provide the necessary support and expertise to industrial partners, the mission of the Technology Transfer Office is to identify their medium/long-term strategic...
-
Article | 2020.10.05
DEVELOPMENT OF INNOVATION
Development Of InnovationMichel Perez,Head of OfficeThe Development of Innovation Office works with researchers to develop their inventions throughout the acceleration and maturation phases by bringing industrial development skills and helping in attracting specific external funding.This office is composed of scientists with strong background in industrial research and development.The...
-
News | 2020.10.05
New Free On-Line Course Created By Institut Pasteur: Clinical Trials In Infectious And TropicalL Diseases
While clinical research has developed for many years in high income countries, it is becoming increasingly important in countries with limited resources. Indeed, beyond common pathologies, specific pathologies such as infectious and tropical diseases make it necessary to conduct trials adapted to the context of countries with limited resources. In addition, re-evaluations of therapeutic or...
-
News | 2020.10.05
New Edition Of The Free On-Line Mooc Malaria
Malaria remains a major public health problem in many low and middle-income countries in the tropics. In 2018, WHO estimates that there were around 228 million cases of malaria that caused 405,000 deaths, primarily in sub-Saharan Africa. While the intensive application of currently available malaria control tools has greatly reduced malaria transmission in many parts of the world where malaria is...
-
Document de presse | 2020.10.08
AIDS: Furthering Knowledge of Natural HIV Infection Control Mechanisms
A further step has just been taken in understanding the mechanisms that allow some individuals to control HIV infection without treatment.A research team led by Dr. Asier Sáez-Cirión (Institut Pasteur) and Dr. Bruno Vaslin (IDMIT[1], CEA-Inserm-Université Paris Saclay) observed for the first time that the antiviral activity of CD8+ T cells of "controller" macaques infected with the simian...
-
News | 2020.10.12
A feedback on 10 months of mobilization of the Institut Pasteur against covid-19
On Thursday, October 8, 2020, the Institut Pasteur in Paris organized an exceptional digital conference to review 10 months of mobilization against Covid-19, a force still in action for global health. Four experts from the Institut Pasteur were present to talk about the epidemic, tests, treatments, vaccines, scientific modelling, and answer questions from Internet users. This conference is...
-
News | 2020.10.13
Hepatitis B: new guidelines for treating HBV-positive pregnant women
Hepatitis B is a viral infection that can be fatal. Most chronic forms are caused by mother-to-child transmission. To avoid this transmission, the World Health Organization (WHO) decided to add new recommendations to its existing guidelines. Yusuke Shimakawa, an expert at the Institut Pasteur in Paris, was given the task of producing two systematic reviews to help determine the nature of the new...
